• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

ARTIS Ventures Closes $200M TechBio Fund to Support Next Era of Health & Medicine Innovation

by Jasmine Pennic 12/14/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– ARTIS Ventures, a pioneer in this “TechBio” revolution, announces the closing of its second fund, TechBio II, with $200M focused on healthcare and biology innovation.

– The fund aims to support early-stage companies to transform human health and well-being by leveraging growing data sets, advanced analytics, and insights.

TechBio II Investment Thesis

Diseases once deemed incurable now have hope, personalized therapies are becoming a reality, and the human body is being understood with unprecedented precision. This convergence of technology and medicine is TechBio, and ARTIS is committed to its growth. ARTIS’s new $200M TechBio II fund seeks to empower early-stage companies with the potential to not only create immense value but also deliver significant societal impact.

Their investment philosophy is guided by six key principles:

– Think Global: Platforms with global reach hold the key to driving the most meaningful change.

– Leave No One Behind: ARTIS prioritizes funding solutions for neglected diseases and aims for universal benefit.

– Transform Systems: From hospitals to homes, they seek innovations that revolutionize care delivery across the spectrum.

– Embrace Diversity: A belief that diverse perspectives fuel breakthrough solutions drives their commitment to a diverse portfolio.

– Persist with Grit: Transforming entrenched systems requires unwavering perseverance, and ARTIS supports founders with the tenacity to overcome challenges.

– Stay Focused: Navigating complex healthcare and biology landscapes demands specialized expertise and strategic vision.

“The age of TechBio brings with it tremendous hope and possibility. United by our common humanity and shared desire for health and well-being, we now have innovations at our fingertips that can alleviate suffering for millions. The future looks brighter than ever, and the only limit to progress is our imagination. If we dream it, we can achieve it,” said Stuart Peterson & Vasudev Bailey, Managing Partners, ARTIS Ventures in the announcement.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Redesign Health Study: 71% of Health Systems Adopt an "Epic-First" AI Purchasing Strategy

Redesign Health Study: 71% of Health Systems Adopt an “Epic-First” AI Purchasing Strategy

iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

mount-sinai-launches-epic-chart-with-art-nursing-ambient-ai

Mount Sinai Medical Center Extends Epic’s Ambient AI to Inpatient Nursing

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

Why Brain Health Is Entering Its Infrastructure Era

Brain Health’s Infrastructure Era: Proving Clinical Outcomes with Integrated Neuromotor Tracking

Why Catholic Health Inked a $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

Catholic Health Inks $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |